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I. Introduction 
A widely used method for the study of polypeptide 
hormone-receptor interactions i the chemical 
synthesis of hormone analogues and the comparison 
of their biological properties [ 1 ]. As a result, it has 
become clear that ACTH is a molecule with sychnolo- 
gical organization, meaning that discrete sequences of 
adjacent amino acids ('continuate words') are 
responsible for different components of its total 
Abbreviations of amino acids and peptides according to the 
recommendations of the 'IUPAC-IUB Joint Commission on 
Biochemical Nomenclature', .g. Eur. J. Biochemistry 1, 
375 (1976). The one-letter notation used here correlates 
as follows: Ala = A, Arg = R, Ash = N, Asp = D, Cys = C, 
Gin = Q, Glu = E, Gly = G, His = H,Ile = I, Leu = L, Lys = K, 
Met = M, Phe = F, Pro = P, Ser = S, Thr = T, Trp = W, Tyr = Y, 
Val = V. Other abbreviations are: ACTH=adrenocortico- 
trophic hormone, cAMP = cyclic 3',5'-AMP, a-MSH = alpha 
melanocyte stimulating hormone. 
biological activity [2]. Thus, ACTH-(4-10)-hepta- 
peptide (ACTH4_ 1o) is a message sequence ('active 
site') responsible for stimulating the receptors, and 
ACTH-(11-24)-tetradecapeptide (ACTH11 - 24) an 
address equence supplying specific affinity for the 
occupation of rat fat cell and adrenal cell,receptors 
(for references and a more thorough discussion 
see [3,4] ). 
As in our studies on a-MSH [3,4], we were interested 
in the question whether or not the message sequence 
can further be subdivided into stretches with 
different biological information. To this end, ACTH 
fragments containing the address equence and 
adjacent parts of the message were prepared by con- 
ventional synthetic methods and tested for their 
ability to enhance lipolysis in isolated rat fat cells 
and to activate adenylate cyclase (cAMP production 
by rat adipocyte membrane preparations, 'ghosts'). 
Human ACTH and the peptides used in this study have 
the following amino acid sequences (message in 
italics): 
SYSMEHFR WGKPVGKKRRPVKVYPNGAEAESAEAFPLEF 
SYSMEHFR WGKPVGKKRRPVKVYP 
EHFR WGKPVGKKRRPVKVYP 
FR ICGKPVGKKRRPVKVYP 
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It was found that the longer fragment, ACTHs-24, 
and its N(tx)-benzyloxycarbonyl derivative, ZACTHs - 24, 
can (like ACTH and ACTH1 _ 24) stimulate both 
lipolysis and cAMP production. The shorter peptides, 
ACTH7_ :4 and ZACTHT_ :4, stimulate adenylate 
cyclase to practically the same extent as ACTHs_ 24, 
but do not enhance lipolysis. Other hormone 
analogues (which we are preparing) will be nebessary 
to describe the specific ontributions to such a 
differential ctivity by the individual amino acid 
residues 5(Glu), 6(His), 7(Phe), 8(Arg), and 9(Trp). 
This type of differential behaviour has - to our 
knowledge - not been previously published, except 
for the observation that glucagon stimulates rabbit 
adenylate cyclase, but fails to stimulate lipolysis [5]. 
No extrapolations to other hormones, actions, or 
cell-types can be made at the moment. However, 
preliminary experiments by W. Schlegel in this 
laboratory suggest an analogous behaviour of our 
compounds towards bovine adrenal cortex cells and 
purified cell membrane vesicles. 
2. Experimental 
ACTH1-24 was prepared according to [6], 
ACTHs _ 24, ACTH7 _ :4, and their N(a)-benzyloxy- 
carbonyl derivatives, ZACTHs_ 24 and ZACTH7_ 24, 
by appropriate modifications of the procedure. All 
compounds were analytically pure (to be published 
in Helv. Chim. Acta). 
Adipocytes and fat cell ghosts were prepared from 
epididymal dipose tissue of male rats weighing 
180--200 g according to the procedures of Rodbell" 
[7,8]. Lipolysis rates were measured as nanomoles of 
glycerol produced by about 7800 cells (= 1 mg cell 
dry weight, cdw) in 30 min [9-11 ]. 
Adenylate cyclase activity was measured by the 
methods of Ramachandran [12] and Salomon et al. 
[13] and expressed as nano- or picomoles of cAMP 
produced in 15 min per 1 mg of cell ghost protein. 
3. Results 
Stimulation of lipolysis and adenylate cyclase 
activity by the ACTH fragments in adipocytes and 
adipocyte ghosts, respectively, is displayed as log 
dose-response (LDR) curves in fig. 1; cAMP produc- 
tion and lipolytic rates were calculated as the 
difference between stimulated and control values. 
ACTHs_24 behaves as a partial agonis* [14] for 
lipolysis (intrinsic activity relative to ACTHl-:4, 
tx = 0.6) with a potency about 275 times less than 
that of ACTH1 _ 24. ZACTHs_ 24 is a full agonist and 
about 20 times more potent han ACTHs _ 24 (however, 
the LDR curve is less steep and could be interpreted 
as consisting of two superposed curves with different 
potency and intrinsic activity parameters). Both 
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Fig.1. Log dose-response curves of the ACTH analogues 
ACTHt -'24, ACTHs-24, ZACTHs-24, ACTH7-24, and 
ZACTH7-24 for lipolytic rates with isolated rat fat cells 
and for adenylate cyclase activation (rates of cAMP produc- 
tion) with rat adipocyte ghosts. 
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Maximat stimulation of adenylate cyctase activity in rat adipocyte ghosts by 3.10-6M ACTH analogues 
in percent of the normatized, unstimutatecl control activity. 
Fig.2. Mean maximal stimulation of adenylate cyclase activity in rat adipocyte ghosts by 3 X 10 -6 M ACTH analogues in percent 
of the normalized, unstimulated control activity. Deviations as 95% confidence limits. Experiments 1-9: ACTH 1 -~4 = 524 -+ 74% 
(P < 0.001), ACTH s -~4 =' 150 +- 25% (P < 0.001), ACTH7-24 =. 126 ± 19% (P < 0.01). Experiments 3,4, 7, 8, 9:ACTH1 --~4 = 
593 -+ 112% (P < 0.001), ACTH 5_~4 = 186 +- 30% (P < 0.001), ACTH 7 -2, = 161 -* 21% (P < 0.001). 
compounds are partial agonists for adenylate cyclase 
activation (a = 0.1-0.2) with potencies comparable 
to that of ACTH1 _ 24. The LDR curves all reach a 
maximum, not a plateau, probably indicative of 
adenylate cyclase inhibition by high hormone dosis. 
ACTHT_ 24 and ZACTH7_ 24 do not stimulate 
lipolysis, in fact, they act as competitive inhibitors 
for ACTH1-24 (Ki about 10-4). However, they are 
also partial agonists for adenylate cyclase stimulation 
(c~ = 0.1). 
Because of this unexpected finding, over 30 com- 
parative xperiments with 9 different ghost prepara- 
tions were performed, using the improved cAMP 
assay [ 13]. The results were statistically evaluated 
in 3 groups: (a) all ghost preparations, nos. 1-9,  
(b) those in which ACTHs_ 24 was active, nos. 
3, 4, 7, 8, 9, and (c) those which were not stimulated 
by ACTHs_24, nos. 1, 2, 5, 6. ACTHT_24 was found 
also to be active in the first two groups and its activity 
to be indistinguishable from that of ACTHs -24 on 
the 5% level (P > 0.05), see fig.2. 
4.  D iscuss ion  
Three conclusions can readily be drawn from these 
results: (1) The octadecapeptide ACTH~_ 24 with 
N-terminal Phe-Arg -Trp -G ly -  suffices to stimulate 
adipocyte ghost adenylate cyclase; however, additional 
amino acids in positions 6 and perhaps 5 (G lu -H is - )  
are required for producing lipolysis in isolated fat 
cells. (2) The N(o0-benzyloxycarbonyl residue can 
cause the partial agonist ACTHs _ 24 to become a full 
lipolytic agonist, it also enhances its intrinsic activity 
on ghost adenylate cyclase to some extent. (3) The 
stimulation of ghost adenylate cyclase by ACTHT_ 24 
is an insufficient condition for evoking lipolysis in 
whole cells. 
The first conclusion fits well into the general 
picture of the one-dimensional organization of 
pleiotropic information in molecules of the ACTH- 
MSH-lipotropin family [3,4], where different 
sequences of adjacent amino acid residues erve 
different biological functions. It suggests that the 
receptor on the adipocyte surface that eventually 
produces lipolysis has different requirements for 
stimulation than the adipocyte ghost receptor that 
activates adenylate cyclase. 
In the second conclusion, the role of the N(a)- 
benzyloxycarbonyl residue can best be compared to 
that of methionine-(4), which it replaces. This residue 
probably acts as a llpophilic contact o the receptor 
[4,15-17],  producing additional binding forces 
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(enhanced potency and intrinsic activity. It might 
well be that the slight increase of cAMP production 
caused by ZACTHs_ ~ over that of ACTHs_ 24 
(fig. 1, this has not yet been verified statistically) 
could be the cause for restoring full lipolytic 
agonism. 
The third conclusion is, of course, very unexpected. 
Usually - in adipocytes and other cells - hormonal 
adenylate cyclase activation is found to correlate 
well with hormonal effects on whole cells [ 18-21] ,  
much better than cAMP accumulation does 
[9,10,22-24].  The observation that ACTHT_ 24 
stimulates ghost adenylate cyclase to almost the same 
extent as ACTHs _ ~,  but fails to enhance lipolysis 
in whole cells might be explained in three ways: (1) 
ACTH7_ 24 fails to stimulate adenylate cyclase in 
whole cells. In this case, the ACTH receptors in 
ghosts would differ from those in whole cells by 
recognizing for some unknown and unusual, specific 
reason ACTHT_ 24 as a stimulus. (2) ACTH 7_ 
enhances cAMP production in whole cells, but this 
cAMP finds itself in the wrong 'compartment' (e.g. in 
one in which it is very rapidly destroyed). This is 
tantamount to saying that discrete hormonal effects 
depending on amino acid residues I-Iis-(6) and, 
perhaps, Glu-(5) are indispensable for 'guiding ~[25] 
cAMP into stimulation of the llpolytic response. (3) 
Other receptors than adenylate cyclase receptors, e.g. 
Ca~-activating receptors [26,27], have to be 
stimulated in order to produce the observed immediate 
lipolytic response. Such receptors would not be 
stimulated by ACTHT_ 24, but only by ACTHs _ ~4 
and ZACTHs _ 24. (Arguments 2 and 3 are, of course, 
logically very closely connected.) Much more work 
will be needed to decide the issue. 
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